Joyce M S Chan1, Claudia Monaco2, Marzena Wylezinska-Arridge3, Jordi L Tremoleda4, Jennifer E Cole2, Michael Goddard2, Maggie S H Cheung5, Kishore K Bhakoo6, Richard G J Gibbs7. 1. Department of Surgery, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, United Kingdom; Regional Vascular Unit, St Mary's Hospital, Imperial College Healthcare National Health Service Trust, Imperial College London, London, United Kingdom; The Laboratory of Molecular Imaging, Singapore Bioimaging Consortium, Agency for Science, Technology and Research (ASTAR), Singapore. Electronic address: joycechan@me.com. 2. Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom. 3. Neuroradiological Academic Unit, University of College London Institute of Neurology, University College London, London, United Kingdom. 4. Medical Research Council-Clinical Sciences Centre, Imperial College London, and Centre for Trauma Sciences, Queen Mary University of London, London, United Kingdom. 5. Department of Surgery, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, United Kingdom. 6. The Laboratory of Molecular Imaging, Singapore Bioimaging Consortium, Agency for Science, Technology and Research (ASTAR), Singapore. 7. Regional Vascular Unit, St Mary's Hospital, Imperial College Healthcare National Health Service Trust, Imperial College London, London, United Kingdom.
Abstract
OBJECTIVE: Identification of patients with high-risk asymptomatic carotid plaques remains an elusive but essential step in stroke prevention. Inflammation is a key process in plaque destabilization and a prelude to clinical sequelae. There are currently no clinical imaging tools to assess the inflammatory activity within plaques. This study characterized inflammation in atherosclerosis using dual-targeted microparticles of iron oxide (DT-MPIO) as a magnetic resonance imaging (MRI) probe. METHODS: DT-MPIO were used to detect and characterize inflammatory markers, vascular cell adhesion molecule 1 (VCAM-1). and P-selectin on (1) tumor necrosis factor-α-treated cells by immunocytochemistry and (2) aortic root plaques of apolipoprotein-E deficient mice by in vivo MRI. Furthermore, apolipoprotein E-deficient mice with focal carotid plaques of different phenotypes were developed by means of periarterial cuff placement to allow in vivo molecular MRI using these probes. The association between biomarkers and the magnetic resonance signal in different contrast groups was assessed longitudinally in these models. RESULTS: Immunocytochemistry confirmed specificity and efficacy of DT-MPIO to VCAM-1 and P-selectin. Using this in vivo molecular MRI strategy, we demonstrated (1) the DT-MPIO-induced magnetic resonance signal tracked with VCAM-1 (r = 0.69; P = .014), P-selectin (r = 0.65; P = .022), and macrophage content (r = 0.59; P = .045) within aortic root plaques and (2) high-risk inflamed plaques were distinguished from noninflamed plaques in the murine carotid artery within a practical clinical imaging time frame. CONCLUSIONS: These molecular MRI probes constitute a novel imaging tool for in vivo characterization of plaque vulnerability and inflammatory activity in atherosclerosis. Further development and translation into the clinical arena will facilitate more accurate risk stratification in carotid atherosclerotic disease in the future.
OBJECTIVE: Identification of patients with high-risk asymptomatic carotid plaques remains an elusive but essential step in stroke prevention. Inflammation is a key process in plaque destabilization and a prelude to clinical sequelae. There are currently no clinical imaging tools to assess the inflammatory activity within plaques. This study characterized inflammation in atherosclerosis using dual-targeted microparticles of iron oxide (DT-MPIO) as a magnetic resonance imaging (MRI) probe. METHODS:DT-MPIO were used to detect and characterize inflammatory markers, vascular cell adhesion molecule 1 (VCAM-1). and P-selectin on (1) tumor necrosis factor-α-treated cells by immunocytochemistry and (2) aortic root plaques of apolipoprotein-E deficient mice by in vivo MRI. Furthermore, apolipoprotein E-deficientmice with focal carotid plaques of different phenotypes were developed by means of periarterial cuff placement to allow in vivo molecular MRI using these probes. The association between biomarkers and the magnetic resonance signal in different contrast groups was assessed longitudinally in these models. RESULTS: Immunocytochemistry confirmed specificity and efficacy of DT-MPIO to VCAM-1 and P-selectin. Using this in vivo molecular MRI strategy, we demonstrated (1) the DT-MPIO-induced magnetic resonance signal tracked with VCAM-1 (r = 0.69; P = .014), P-selectin (r = 0.65; P = .022), and macrophage content (r = 0.59; P = .045) within aortic root plaques and (2) high-risk inflamed plaques were distinguished from noninflamed plaques in the murine carotid artery within a practical clinical imaging time frame. CONCLUSIONS: These molecular MRI probes constitute a novel imaging tool for in vivo characterization of plaque vulnerability and inflammatory activity in atherosclerosis. Further development and translation into the clinical arena will facilitate more accurate risk stratification in carotid atherosclerotic disease in the future.
Authors: Zahi A Fayad; Filip K Swirski; Claudia Calcagno; Clinton S Robbins; Willem Mulder; Jason C Kovacic Journal: J Am Coll Cardiol Date: 2018-10-30 Impact factor: 24.094
Authors: Maxime Gauberti; Antoine P Fournier; Fabian Docagne; Denis Vivien; Sara Martinez de Lizarrondo Journal: Theranostics Date: 2018-02-02 Impact factor: 11.556
Authors: Nataliya V Mushenkova; Volha I Summerhill; Dongwei Zhang; Elena B Romanenko; Andrey V Grechko; Alexander N Orekhov Journal: Int J Mol Sci Date: 2020-04-23 Impact factor: 5.923
Authors: Joyce M S Chan; Park Sung Jin; Michael Ng; Joanne Garnell; Chan Wan Ying; Chong Tze Tec; Kishore Bhakoo Journal: Transl Stroke Res Date: 2021-07-25 Impact factor: 6.829